News
AXGN
34.51
+1.71%
0.58
Axogen Inc. to Report Financial Results and Host Investor Call
Reuters · 1d ago
Axogen Inc. veröffentlicht eine Aktualisierung ihres Finanzkalenders
Reuters · 1d ago
Weekly Report: what happened at AXGN last week (0202-0206)?
Weekly Report · 2d ago
Wasatch Micro Cap Fund Q4 2025 Performance Review
Seeking Alpha · 02/04 13:35
AxoGen (AXGN) Receives a Buy from Canaccord Genuity
TipRanks · 02/02 12:09
Weekly Report: what happened at AXGN last week (0126-0130)?
Weekly Report · 02/02 09:21
Are Biotech And Pharma Stocks Poised To Keep Climbing After Hitting 52-Week Highs?
NASDAQ · 01/27 10:34
Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Viking Therapeutics (VKTX)
TipRanks · 01/26 14:03
Weekly Report: what happened at AXGN last week (0119-0123)?
Weekly Report · 01/26 09:20
AxoGen Announces Equity Offering to Repay Term Loan
TipRanks · 01/23 12:29
AXOGEN INC - FILES FOR OFFERING OF UP TO 4 MLN SHARES OF COMMON STOCK - SEC FILING
Reuters · 01/23 12:02
Axogen Prices Upsized $124 Million Stock Offering
Benzinga · 01/22 17:42
Axogen Slips After Pricing $124M Upsized Share Offering
NASDAQ · 01/22 14:35
Jefferies Keeps Their Buy Rating on AxoGen (AXGN)
TipRanks · 01/22 14:15
AxoGen 4M share Spot Secondary priced at $31.00
TipRanks · 01/22 13:46
BUZZ-Axogen slides on surgical device maker's $124 mln stock sale
Reuters · 01/22 12:36
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 01/22 12:05
Axogen stock dips after pricing $124M offering
Seeking Alpha · 01/22 11:44
Biggest stock movers Thursday: DDOG, BABA, and more
Seeking Alpha · 01/22 10:01
*Axogen Offering Managed by Wells Fargo Securities, Mizuho >AXGN
Dow Jones · 01/22 04:45
More
Webull provides a variety of real-time AXGN stock news. You can receive the latest news about Axogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About AXGN
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.